Polyomavirus BK infection in blood and marrow transplant recipients

Bone Marrow Transplantation

Volumn 41, Issue 1, 2008, Pages 11-18

  Dropulic, L K ^a   Jones, R J ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACROLEIN; ALUMINUM POTASSIUM SULFATE; ANTIVIRUS AGENT; BUSULFAN; CEPHALOSPORIN; CIDOFOVIR; CIPROFLOXACIN; CYCLOPHOSPHAMIDE; DNA POLYMERASE; ETOPOSIDE; FORMALDEHYDE; GATIFLOXACIN; IFOSFAMIDE; LEFLUNOMIDE; OFLOXACIN; PROSTAGLANDIN E1; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RITUXIMAB; VIRUS DNA;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIVIRAL ACTIVITY; BK VIRUS; BLADDER IRRIGATION; BLOOD ANALYSIS; BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; CYSTECTOMY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; GENE AMPLIFICATION; HEMORRHAGIC CYSTITIS; HUMAN; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL NEPHRITIS; LOW DRUG DOSE; MENINGITIS; MENINGOENCEPHALITIS; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECIPIENT; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; URINALYSIS; URINARY TRACT INFECTION; VIRUS DETECTION; VIRUS INFECTION; VIRUS LOAD; VIRUS PNEUMONIA; VIRUS REPLICATION; VIRUS SHEDDING; VIRUS TRANSMISSION;

BK VIRUS; BONE MARROW TRANSPLANTATION; CYSTITIS; HEMORRHAGE; HUMANS; POLYOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS; VIRAL LOAD;

EID: 38349038145     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705886     Document Type: Review

References (82)

1. Gardner SD, Field AM, Coleman DV, Hulme B. New papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1971; 1 253-257.
2. Arthur RR, Shah KV, Baust SJ, Santos GW, Saral R. Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. N Engl J Med 1986; 315: 230-234.
3. Arthur RR, Shah KV, Charache P, Saral R. BK and JC virus infections in recipients of bone marrow transplants. J Infect Dis 1988; 158 563-569.
4. Apperley JF, Rice SJ, Bishop JA, Chia YC, Krausz T, Gardner SD et al Late-onset hemorrhagic cystitis associated with urinary excretion of polyomaviruses after bone marrow transplantation. Transplantation 1987; 43: 108.
5. Pappo O, Demetris AJ, Raikow RB, Randhawa PS. Human polyoma virus infection of renal allografts: Histopathologic diagnosis, clinical significance, and literature review. Mod Pathol 1996; 9: 105-109.
6. Randhawa PS, Demetris AJ. Nephropathy due to polyomavirus type BK. N Engl J Med 2000; 342: 1361-1363.
7. Hirsch HH, Steiger J. Polyomavirus BK. Lancet Infect Dis 2003; 3: 611-623.
8. Khalili K, Gordon J, White MK. The polyomavirus, JCV and its involvement in human disease. Adv Exp Med Biol 2006; 577: 274-287.
9. Yousry TA, Major EO, Ryschkewitsch C, Fahle G, Fischer S, Hou J et al Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N Engl J Med 2006; 354: 924-933.
10. Steurer M, Clausen J, Gotwald T, Gunsilius E, Stockhammer G, Gastl G et al. Progressive multifocal encephalopathy after allogeneic stem cell transplantation and posttransplantation rituximab. Transplantation 2003; 76: 435-436.
11. Milstone A, Vilchez RA, Geiger X, Fogo AB, Butel JS, Dummer S. Polyomavirus simian virus 40 infection associated with nephropathy in lung-transplant recipient. Transplantation 2004; 77: 1019-1024.
12. Li RM, Branton MH, Tanawattanacharoen S, Falk RA, Jennette JC, Kopp JB. Molecular identification of SV40 infection in human subjects and possible association with kidney disease. J Am Soc Nephrol 2002; 13: 2320-2330.
13. Goudsmit J, Wertheim-van Dillen P, van Strien A, van der NJ. The role of BK virus in acute respiratory tract disease and the presence of BK virus DNA in tonsils. J Med Virol 1982; 10: 91-99.
14. Reploeg MD, Storch GA, Clifford DB. BK virus: A clinical review. Clin Infect Dis 2001; 33: 191-202.
15. Coleman DV, Gardner SD, Mulholland C, Fridiksdottir V, Porter AA, Lilford R et al. Human polyomavirus in pregnancy a model for the study of defense mechanisms to virus reactivation. Clin Exp Immunol 1983; 53: 289-296.
16. Kitumura T, Aso Y, Kuniyoshi N, Hara K, Yogo Y. High incidence of urinary JC virus excretion in nonimmunosuppressed older patients. J Infect Dis 1990; 161: 1128-1133.
17. Behzad-Behbahani A, Klapper PE, Vallely PJ, Cleator GM, Khoo SH. Detection of BK virus and JC virus DNA in urine samples in immunocompromised (HIV-infected) and immunocompetent (HIV-non-infected) patients using polymerase chain reaction and microplate hybridization. J Clin Virol 2004; 29: 224-229.
18. Munoz P, Fogeda M, Bouza E, Verde E, Palomo J, Banares R. Prevalence of BK virus replication among recipients of solid organ transplants. Clin Infect Dis 2005; 41: 1720-1725.
19. Bedi A, Miller CB, Hanson JL, Goodman S, Ambinder RF, Charache P et al. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol 1995; 13: 1103-1109.
20. Azzi A, Cesaro S, Laszlo D, Zakrzewska K, Ciappi S, De Santis R et al Human polyomavirus BK (BKV) load and hemorrhagic cystitis in bone marrow transplant patients. J Clin Virol 1999; 14: 79-86.
21. Anderson EE, Cobb OE, Glenn JF. Cyclophosphamide hemorrhagic cystitis. J Urol 1967; 97: 857-858.
22. Cox PJ. Cyclophosphamide cystitis - identification of acrolein as the causative agent. Biochem Pharmacol 1979; 28: 2045-2049.
23. Droller MJ, Saral R, Santos G. Prevention of cyclophosphamide-induced hemorrhagic cystitis. Urology 1982; 20: 256-258.
24. Leung AYH, Seun CKM, Lie AKW, Liang RHS, Yuen KY, Kwong YL. Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation. Blood 2001; 98: 1971-1978.
25. Wong SY, Chan K-H, Cheng VCC, Yuen K-Y, Kwong Y-L, Leung AYH. Relationship of pretransplantation polyoma BK virus serologic findings and BK viral reactivation after hematopoietic stem cell transplantation. Clin Infect Dis 2007; 44: 830-837.
26. Bogdanovic G, Priftakis P, Giraud G, Kuzniar M, Ferraldeschi R, Kokhaei P et al. Association between a high BK virus load in urine samples of patients with graft-versus-host disease and development of hemorrhagic cystitis after hematopoietic stem cell transplantation. J Clin Microbiol 2004; 42: 5394-5396.
27. Nickeleit V, Klimkait T, Binet IF, Dalquen P, Del Zenero V, Thiel G et al. Testing for polyomavirus type BK DNA in plasma to identify renal allograft recipients with viral nephropathy. N Engl J Med 2000; 342: 1309-1315.
28. Erard V, Kim HW, Corey L, Limaye A, Huang M-L, Myerson D et al. BK DNA viral load in plasma: Evidence for an association with hemorrhagic cystitis in allogeneic hematopoietic cell transplant recipients. Blood 2005; 106: 1130-1132.
29. Leung AYH, Mak R, Lie AKW, Yuen KY, Cheng VCC, Liang R et al. Clinicopathological features and risk factors of clinically overt hemorrhagic cystitis complicating bone marrow transplantation. Bone Marrow Transplant 2002; 29: 509-513.
30. Leung AYH, Chan M, Cheng VCC, Lie AKW, Yuen K-Y, Kwong Y-L. Polyoma BK viruria in patients undergoing autologous hematopoietic stem cell transplantation. Bone Marrow Transplant 2005; 35: 1029-1030.
31. Seber A, Shu XO, Defor T, Sencer T, Ramsay N. Risk factors for severe hemorrhagic cystitis following BMT. Bone Marrow Transplant 1999; 23: 35-40.
32. Binet I, Nickeleit V, Hirsch HH. Polyomavirus infections in transplant recipients. Curr Opin Organ Transplant 2000; 5: 210-216.
33. Cheng VCC, Yuen K-Y, Chan W-M, Wong SSY, Edmond SKM, Chan RMT. Immune reconstitution disease involving the innate and adaptive responses. Clin Infect Dis 2000; 30: 882-892.
34. Safdar A, Rubocki RJ, Horvath JA, Narayan KK, Waldron RL. Fatal immune restoration disease in human immunodeficiency virus type-1 infected patients with progressive multifocal leukoencephalopathy: Impact of antiretroviral therapy-associated immune reconstitution. Clin Infect Dis 2002; 35: 1250-1257.
35. D'Amico R, Sarkar S, Yusuff J, Azar E, Perlman DC. Immune reconstitution after potent antiretroviral therapy in AIDS patients with progressive mutifocal leukoencephalopathy. Scand J Infect Dis 2007; 39: 347-350.
36. Leung AYH, Yuen K-Y, Kwong Y-L. Polyoma BK virus and haemorrhagic cystitis in haematopoietic stem cell transplantation: A changing paradigm. Bone Marrow Transplant 2005; 36: 929-937.
37. Fogazzi GB, Cantu M, Saglimbeni L. Decoy cells in the urine due to polyomavirus BK infection: Easily seen by phase contrast microscopy. Nephrol Dial Transplant 2001; 16: 1496-1498.
38. Ambinder RF, Burns W, Forman M, Charache P, Arthur R, Beschorner W et al. Hemorrhagic cystitis associated with adenovirus infection in bone marrow transplantation. Arch Int Med 1986; 146: 1400-1401.
39. Akiyama H, Kurosu T, Sakashita C, Inoue T. Adenovirus is a key pathogen in hemorrhagic cystitis associated with bone marrow transplantation. Clin Infect Dis 2001; 32: 1325.
40. Spach DH, Bauwens JE, Myerson D, Mustafa MM, Bowden RA. Cytomegalovirus-induced hemorrhagic cystitis following bone marrow transplantation. Clin Infect Dis 1993; 16, 142-144.
41. Sebe P, Garderet L, Traxer O, Nouri M, Gluckman E, Gattegno B. Subtotal cytectomy with ileocystoplasty for severe hemorrhagic cystitis after bone marrow transplantation. Urology 2001; 571: 168xiv-168xvi.
42. Gorczynska E, Turkiewicz D, Rybka K, Toporski J. Kalwak K, Dyla A et al. Incidence, clinical outcome, and management of virus-induced hemorrhagic cystitis in children and adolescents after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2005; 11: 797-804.
43. De Clercq E, Holy A. Acyclic nucleoside phosphonates: A key class of antiviral drugs. Nat Rev Drug Discov 2005; 4: 928-940.
44. Dunn JP, Van Natta M, Foster G, Kuppermann BD, Martin DF, Zang A et al. Complications of ganciclovir implant surgery ih patients with cytomegalovirus retinitis: The ganciclovir cidifovir cytomegalovirus retinitis trial. Retina 2004; 24: 41-50.
45. Preiksaitis JK, Brennan DC, Fishman J, Allen U. Canadian society of transplantation consensus workshop of cytomegalovirus management in solid organ transplantation final report. Am J Transplant 2005; 5: 218-227.
46. Randhawa P, Farasati NA, Shapiro R, Hostetler KY. Efher lipid ester derivatives of cidofovir inhibit polyomavirus BK replication in vitro. Antimicrob Agents Chemother 2006; 50: 1564-1566.
47. Josephson MA, Williams JW, Chandraker A, Randhawa PS. Polyomavirus-associated nephropathy: Update on antiviral strategies. Transpl Infect Dis 2006; 8: 95-101.
48. Farasati NA, Shapiro R, Vats A, Randhawa P. Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system. Transplantation 2005; 79: 111-118.
49. Vats A, Shapiro R, Randhawa SP, Scantlebury V, Tuzuner A, Saxena M et al. Quantitative viral load monitoring and cidofovir therapy for management of BK virus-associated nephropathy in children and adults. Transplantation 2003; 75: 105-112.
50. Kadambi PV, Josephson MA, Williams J, Corey L, Jerome KR, Meehan SM et al. Treatment of refractory BK virus-associated nephropathy with cidofovir. Am J Transplant 2003; 3: 186-191.
51. Held TK, Biel SS, Nitsche A, Kurth A, Chen S, Gelderblom HR et al. Treatment of BK virus-associated hemorrhagic cystitis and simultaneous CMV reactivation with cidofovir. Bone Marrow Transplant 2000; 26: 347-350.
52. Savona MR, Newton D, Frame D, Levine JE, Mineishi S, Kaul DR. Low-dose cidofovir treatment of BK virus-associated hemorrhagic cystitis in recipients of hematopoietic stem cell transplant. Bone Marrow Transplant 2007; 39: 783-787.
53. Bridges B, Donegan S, Badros A. Cidofovir bladder instillation for the treatment of BK hemorrhagic cystitis after allogeneic stem cell transplantation. Am J Hematol 2006; 81: 531-537.
54. Strand V, Cohen S. Schiff M, Weaver A, Fleischmann R, Cannon G et al. Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Arch Intern Med 1999; 159: 2542-2550.
55. Rinaldo CH, Hirsch HH. Antivirals for the treatment of polyomavirus BK replication. Expert Rev Anti Infect Ther 2007; 5: 105-115.
56. Waldman WJ, Knight DA, Blinder L, Shon J, Lurain NS, Miller DM et al. Inbibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide. Intervirology 1999; 42: 412-418.
57. Williams JW, Javaid B, Kadambi PV, Gillen D, Harland R, Thistlewaite JR et al. Leflunomide for polyomavirus type BK nephropathy. N Engl J Med 2005; 352: 1157-1158.
58. Josephson MA, Gillen MA, Javaid B, Kadambi P, Meehan S, Foster P et al. treatment of renal allograft polyoma BK virus infection with leflunomide. Transplantation 2006; 41: 704-710.
59. Avery RK, Bolwell BJ, Yen-Lieberman B. Lurain N, Waldman WJ, Longworth DL et al. Use df leflunomide in an allogeneic bone-marrow transplant recipient with refractory cytomegalovirus infection. Bone Marrow Transplant 2004; 34: 1071-1075.
60. Battiwalla M, Paplham P, Almyroudis NG, McCarthy A, Abdelhalim A, Elefante A et at. Leflunomide failure to control recurrent cytomegalovirus infection in the setting of renal failure after allogeneic stem cell transplantation. Transpl Infect Dis 2007; 9: 28-32.
61. Ferrazzi E, Peracchi M, Biasolo MA, Faggionato O, Stefanelli S, Palu G et al. Antiviral activity of gyrase inhibitors norfloxacin, coumermycin A1, and nalidixic acid. Biochem. Pharmacol 1988; 37 1885-1886.
62. Portolani M, Pietrosemoh P, Cermelli C, Mannini-Palenzona A, Grossi MP, Paolini L et al. Suppression of BK virus replication and cytopathic effect by inhibitors of prokaryotic DNA gyrase. Antiviral Res 1988; 9: 205-218.
63. Randhawa PS. Anti-BK virus activity of ciprofloxacin and related antibiotics. Clin Infect Dis 2005; 41: 1366-1367.
64. Ali S, Chandraker A, DeCaprio J. Inhibition of polyoma helicase activity by quinolones. J Am Soc Neprhol 2003; 14: 43A.
65. Leung AY, Chan MT, Yuen KY, Cheng VC, Chan KH, Wong CL et al. Ciproftoxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2005; 40: 528-537.
66. Chandraker A, Ali S, Drachenberg CB, Ravinder W, Hirsch H, DeCaprio J et al. Use of fluoroquinolones to treat BK infection in renal transplant recipients. Am J Transplant 2004; 4 (Suppl 8): 587.
67. Limaye AP, Smith KD, Cook L, Groom DA, Hunt NC, Jerome KR et al. Polyomavirus nephropathy in native kidneys of non-renal transplant recipients. Am J Transplant 2005; 5: 614-620.
68. Shapiro S, Robin M, Esperou H, Rocha V, Garnier T, Gluckman E et al Polyornavirus nephropathy in the native kidneys of an unrelated cord blood transplant recipient followed by a disseminated polyomavirus infection. Transplantation 2006; 82: 292-293.
69. Avery RK. BK virus and renal dysfunction. Clin Infect Dis 2005; 41: 1726-1727.
70. Stracke S, Helmchen U, von Muller L, Bunjes D, Keller F. Polyoma virus-associated interstitial nephritis in a patient with acute myeloid leukaemia and peripheral blood stem cell transplantation. Nephrol Dial Transplant 2003; 18: 2431-2433.
71. Gaston K, Gabriel DA, Lavelle JP. Rare cause of ureteral obstruction. Urology 2005; 66: 1110.e5-1110.e6.
72. Stoner GL, Alappan R, Jobes DV, Ryschkewitsch CF, Landry M1. - BK virus regulatory rearrangements in brain and cerebrospinal fluid from a leukemia patient with tubulointerstitial nephritis and meningoencephalitis. Am J Kidney Dis 2002; 39: 1102-1112.
73. Vago L, Cinque P, Sala E, Nebuloni M, Calderelli R, Racca S et al. JCV-DNA and BKV-DNA in the CNS tissue and CSF of AIDS patients and normal subjects. Study of 41 cases and review of the literature. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 12: 139-146.
74. Vallbracht A, Lohler J, Gossmann J, Gluck T, Petersen D, Gerth HJ et al. Disseminated UK type polyomavirus infection in an AIDS patients associated with central nervous system disease. Am J Pathol 1993; 143: 29-39.
75. Jorgensen GE, Hammarin AL, Bratt -G, Grandien M, Flaegstad T, Johnsen JI. Identification of a unique BK virus variant in the CNS of a patient with AIDS. J Med Virol 2003; 70: 14-19.
76. Bratt G, Hammarin AL, Grandien M, Hedquist BG, Nennesmo I, Sundelin B et al. BK virus as the cause of meningoencephalitis, retinitis and nephritis in a patient with AIDS. AIDS 1999; 13: 1071-1075.
77. Lesprit P, Chaline-Lehmann D, Authier FJ, Ponnelle T, Gray F, Levy Y. BK virus encephalitis in a patient with AIDS and lymphorna. AIDS 2001; 15: 1196-1199.
78. Hedquist BG, Bratt G, Hammarin AL, Grandien M, Nennesmo I, Sundelin B et al. Identification of BK virus in a patient with acquired immune deficiency syndrome and bilateral atypical retinitis. Ophthalmology 1999; 106: 129-132.
79. Agostini HT, Ryschkewitsch CF, Singer JE, Stoner GL. JC virus regulatory region rearrangments and genotypes in progressive multifocal leukoencephalopathy: Two independent aspects of virus variation. J Gen Virol 1997; 78: 659-664.
80. Sandler ES, Aquino VM, Goss-Shohet E, Hinrichs S, Krisher K. BK papova virui pneumonia following hematopoietic stem cell transplantation. Bone Marrow Transplant 1997; 20: 163-165.
81. Galan A, Rauch CA, Otis CN. Fatal BK polyoma viral pneumonia associated with immunosuppression. Hum Pathol 2005; 36: 1031-1034.
82. Petrogiannis-Haliotis T, Sakoulas G, Kirby J, Koralnik IJ, Dvorak AM, Monahan-Earley R et al. BK-related polyoma-virus vasculopathy in a renal transplant recipient. N Engl J Med 2001; 345: 1250-1255.